TAAG Genetics

Belkins
TAAG Genetics is a molecular diagnostic research company that develops, manufactures and distributes its products and services of genetic analysis to individuals and companies in the clinical and industrial areas. The diagnostic solutions delivered by TAAG Genetics, focus on the applications that multiplex PCR-based exams can have for our clients, such as the screening of multiple pathogens in medical institutions, food companies, agricultural and environmental areas.

Related News

PHARMA CONSULTING CORP. STRIKES STRATEGIC ALLIANCES WITH MULTINATIONALS

News is my Business | February 25, 2020

news image

Pharma Consulting Corp., a local multidisciplinary firm that offers professional validation services for the pharmaceutical industry, recently entered into strategic alliances with multinational companies Thomas Scientific and MackBick Lab, as part of its growth plans. The women-led trio of firms are looking to support each other in “paving the way for women in the entrepreneurial ecosystem,” said PCC President Charil Pabón, who is a microbiologist. Through these strategic all...

Read More

COVECTRA ANNOUNCES VRS FOR PHARMACEUTICAL MANUFACTURERS TO ENHANCE DRUG SUPPLY CHAIN SECURITY

Covectra | June 22, 2020

news image

Covectra, a leader in track and trace solutions, today announced the Covectra Verification Router Service (VRS), a complete API solution enabling pharmaceutical brands to validate the status of a returned product to ascertain its resell ability and ensure regulatory compliance with the upcoming Drug Supply Chain and Security Act (DSCSA) saleable returns requirement. In November 2020, the FDA enforcement will begin as pharmaceutical distributors of regulated medicines will need to ...

Read More

VIEWS AND ANALYSIS

CMIC AND LOKAVANT COLLABORATE TO DEPLOY MACHINE LEARNING-POWERED CLINICAL TRIAL INTELLIGENCE PLATFORM

CMIC | June 25, 2021

news image

CMIC Co., Ltd., a leading Japanese Contract Research Organization (CRO), and Lokavant, a leading clinical trial intelligence company, announced today that they have agreed to use Lokavant's predictive analytics capabilities to assist CMIC's clinical operations. This strategic collaboration, Lokavant Oversight, monitoring, and operational risk management platform, will be implemented throughout CMIC studies. CMIC was the first firm in Japan to provide CRO services, and the ...

Read More

PHARMA SEES MORE POST-M&A REBRANDS THAN OTHER INDUSTRIES—AND IT DOES THEM BETTER, TOO

Fiercepharma | June 03, 2020

news image

To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries. Pharma, in fact, was the most prolific rebrander in Brand Finance’s recent research assessing the value of rebrands across 25 industries. It's also one of the most successful, with rebrands in pharma generating average returns of 13.8%, according to Brand Finance calculations. The main reason? Most acquired phar...

Read More

News is my Business | February 25, 2020

news image

PHARMA CONSULTING CORP. STRIKES STRATEGIC ALLIANCES WITH MULTINATIONALS

Pharma Consulting Corp., a local multidisciplinary firm that offers professional validation services for the pharmaceutical industry, recently entered into strategic alliances with multinational companies Thomas Scientific and MackBick Lab, as part of its growth plans. The women-led trio of firms are looking to support each other in “paving the way for women in the entrepreneurial ecosystem,” said PCC President Charil Pabón, who is a microbiologist. Through these strategic all...

Read More

Covectra | June 22, 2020

news image

COVECTRA ANNOUNCES VRS FOR PHARMACEUTICAL MANUFACTURERS TO ENHANCE DRUG SUPPLY CHAIN SECURITY

Covectra, a leader in track and trace solutions, today announced the Covectra Verification Router Service (VRS), a complete API solution enabling pharmaceutical brands to validate the status of a returned product to ascertain its resell ability and ensure regulatory compliance with the upcoming Drug Supply Chain and Security Act (DSCSA) saleable returns requirement. In November 2020, the FDA enforcement will begin as pharmaceutical distributors of regulated medicines will need to ...

Read More

VIEWS AND ANALYSIS

CMIC | June 25, 2021

news image

CMIC AND LOKAVANT COLLABORATE TO DEPLOY MACHINE LEARNING-POWERED CLINICAL TRIAL INTELLIGENCE PLATFORM

CMIC Co., Ltd., a leading Japanese Contract Research Organization (CRO), and Lokavant, a leading clinical trial intelligence company, announced today that they have agreed to use Lokavant's predictive analytics capabilities to assist CMIC's clinical operations. This strategic collaboration, Lokavant Oversight, monitoring, and operational risk management platform, will be implemented throughout CMIC studies. CMIC was the first firm in Japan to provide CRO services, and the ...

Read More

Fiercepharma | June 03, 2020

news image

PHARMA SEES MORE POST-M&A REBRANDS THAN OTHER INDUSTRIES—AND IT DOES THEM BETTER, TOO

To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries. Pharma, in fact, was the most prolific rebrander in Brand Finance’s recent research assessing the value of rebrands across 25 industries. It's also one of the most successful, with rebrands in pharma generating average returns of 13.8%, according to Brand Finance calculations. The main reason? Most acquired phar...

Read More